Eledon Pharmaceuticals, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINES-8Eledon Pharmaceuticals, Inc.ELDNSep 4

   Employee stock plan registration

2. NOTABLE10-QEledon Pharmaceuticals, Inc.ELDNAug 13

   Quarterly report

3. ROUTINE8-KEledon Pharmaceuticals, Inc.ELDNAug 13

   Current report

4. ROUTINE4Eledon Pharmaceuticals, Inc.ELDNAug 4

   2 insider filings

   David-Alexandre C Gros, insider filing for ELDN

   Show all 2

   • 4Insider filing for ELDNAug 4
   • 4Insider filing for ELDNAug 4

   David-Alexandre C Gros, reporting

5. ROUTINESCHEDULE 13GEledon Pharmaceuticals, Inc.ELDNJul 31

   Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC

   VANGUARD CAPITAL MANAGEMENT LLC, filed by

6. ROUTINE8-KEledon Pharmaceuticals, Inc.ELDNJun 22

   Current report

7. ROUTINESCHEDULE 13G/AEledon Pharmaceuticals, Inc.ELDNMay 15

   Ownership stake disclosure by BIOTECHNOLOGY VALUE FUND L P (amended)

   BIOTECHNOLOGY VALUE FUND L P, filed by

8. NOTABLE10-QEledon Pharmaceuticals, Inc.ELDNMay 13

   Quarterly report

9. ROUTINE8-KEledon Pharmaceuticals, Inc.ELDNMay 13

   Current report

10. ROUTINEEFFECTEledon Pharmaceuticals, Inc.ELDNMay 12

    Registration declared effective

11. ROUTINES-3Eledon Pharmaceuticals, Inc.ELDNMay 1

    Securities offering

12. ROUTINEDEFA14AEledon Pharmaceuticals, Inc.ELDNApr 30

    Additional proxy materials

13. ROUTINEARSEledon Pharmaceuticals, Inc.ELDNApr 30

    Annual report to shareholders

14. ROUTINEDEF 14AEledon Pharmaceuticals, Inc.ELDNApr 30

    Proxy statement

15. ROUTINESCHEDULE 13GEledon Pharmaceuticals, Inc.ELDNApr 27

    Ownership stake disclosure by BlackRock, Inc.

    BlackRock, Inc., filed by

16. ROUTINESCHEDULE 13G/AEledon Pharmaceuticals, Inc.ELDNMar 26

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

17. NOTABLE10-KEledon Pharmaceuticals, Inc.ELDNMar 19

    Annual report

18. ROUTINE8-KEledon Pharmaceuticals, Inc.ELDNMar 19

    Current report

19. ROUTINESCHEDULE 13G/AEledon Pharmaceuticals, Inc.ELDNFeb 17

    Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)

    RA CAPITAL MANAGEMENT, L.P., filed by

20. ROUTINESCHEDULE 13G/AEledon Pharmaceuticals, Inc.ELDNFeb 13

    Ownership stake disclosure by Coastlands Capital LP (amended)

    Coastlands Capital LP, filed by

21. ROUTINE4Eledon Pharmaceuticals, Inc.ELDNJan 16

    6 insider filings

    June Lee, insider filing for ELDN

    Show all 6

    • 4Insider filing for ELDNJan 16
    • 4Insider filing for ELDNJan 16
    • 4Insider filing for ELDNJan 16
    • 4Insider filing for ELDNJan 16
    • 4Insider filing for ELDNJan 16
    • 4Insider filing for ELDNJan 16

    June Lee, reporting

22. ROUTINE8-KEledon Pharmaceuticals, Inc.ELDNJan 2

    Current report

23. ROUTINESCHEDULE 13GEledon Pharmaceuticals, Inc.ELDNNov 24, 2025

    Eledon Pharmaceuticals, Inc. filed SCHEDULE 13G

    • Form Type: SCHEDULE 13G
    • Filing Date: 2025-11-24

    Coastlands Capital LP, filed by

24. ROUTINE8-KEledon Pharmaceuticals, Inc.ELDNNov 14, 2025

    Current report

25. NOTABLE10-QEledon Pharmaceuticals, Inc.ELDNNov 14, 2025

    Quarterly report

26. ROUTINE424B5Eledon Pharmaceuticals, Inc.ELDNNov 12, 2025

    Securities offering

Older filings on EDGAR